5th Microbiome Movement – Human Nutrition Summit

The COVID-19 pandemic has improved consumer consciousness of the importance of establishing good baseline health including immunity and gut health, and recent advances in microbiome research from the nutritional and therapeutic industries are highlighting the possibility to make significant improvements to human health via the microbiome. Therefore, the opportunity to transform health and reduce risk of disease through human nutritional interventions is being catapulted into the spotlight for both industry and consumers alike.

The 5th Microbiome Movement – Human Nutrition Summit is your unrivaled opportunity to join 100+ key decision makers from CPG companies, start-ups and personalized nutrition companies to stay abreast of cutting-edge research, applied and clinical science, as well as commercial strategy to further advance your products efficacy and optimize consumer buy-in.

Covering the next generation of microbiome targeted nutritional interventions, food versus pharma, clinical trial design and execution, personalized nutrition, and the regulatory landscape, our industry leading program will connect you with your peers to obtain the insights required to transform your research and branding efforts to establish yourself as a thought leader within this growing industry.

Group discounts, academic and early booking rates are available. Please visit the website for full pricing information.

Tickets https://go.evvnt.com/828309-1?pid=176 
Brochure https://go.evvnt.com/828309-3?pid=176 

Prices:
Conference + Pre-Conference Focus Day (Industry) USD 2698.00
Conference Only (Industry) USD 1999.00
Conference + Pre-Conference Focus Day (Solution & Service Provider) USD 3098.00
Conference Only (Solution & Service Provider) USD 2299.00
Conference + Pre-Conference Focus Day (Academic) USD 1678.00
Conference Only (Academic) USD 1279.00

Speakers: Richard Day, Director, Medical Affairs, ADM, Alice Eggleston, Physician Assistant, Atlantia Clinical Trials, Katie Harris, Product Development & Nutrition Scientist, Bay State Milling, Nalin Siriwardhana, Senior Associate Director, Global & US Medical Category, Allergy & Cough Cold, Bayer Consumer Health, David Evendon, Challis CSO, Bayer Consumer Health, Matthew Amicucci, Co-Founder & Principal Scientist, BCD Bioscience, Afif Ghannoum, CEO & Co-Founder, BIOHM Health, Luc Sterkman, CEO, Caelus Health, Lucien Harthoorn, Director, R&D, Clasado Bioscience, Miguel Freitas, VP, Health & Scientific Affairs, Danone North America, Lihi Segal, Founder & CEO, DayTwo, Ross Pelton, Scientific Director, Essential Formulas, Marc Tewey, CEO, ExeGi Pharma, Carolina Barsa, Chief Innovation & Growth Officer, Fitbiomics, Jonathan Scheiman, CEO, Fitbiomics, Andre Groeneveld, Senior Discovery Manager, FriesLandCampina, Saikiran Chaluvadi, VP, R&D, Harris Tea Company, Shahram Lavasani, CEO, ImmuneBiotech, Solange Henoud, Director, Global Regulatory Affairs, Lallemand, Chyn Boon Wong, Research Associate, Morinaga Milk, Thomas Gurry, Founder & CEO, myota, Colleen Cutcliffe, CEO, Pendulum Therapeutics, Aubrey Levitt, Co-Founder, Postbiotics Plus, Jonas Schluter, Co-Founder, Postbiotics Plus, Vivek Lal Founder, & President, ReBiotic Inc., Gerardo Toledo, CEO, Solarea Bio, Zac Lewis, CSO, Synbiotic Health, Gregory Lambert, CEO, TargEDys SA, Lisa MacFarlane, Co-CEO & Co- Founder, The Gut Stuff, Len Monheit, Executive Director, Global Prebiotic Association, Simone Pyle, Science & Technology Manager, Unilever, Kara Landau, CEO, Uplift Food, Zack Abbott, CEO, Zbiotics

Time: On Monday November 08, 2021 at 9:00 am (ends Wednesday November 10, 2021 at 4:00 pm)